{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:40:32Z","timestamp":1790862032198,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2009,7,1]]},"DOI":"10.2174\/138161209788682244","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T01:05:52Z","timestamp":1246496752000},"page":"2508-2519","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase"],"prefix":"10.2174","volume":"15","author":[{"given":"M.","family":"Andreola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/69595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T13:45:30Z","timestamp":1448027130000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=15&issue=21&spage=2508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":0,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,7,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161209788682244","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}